Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Investigation Determining the Discriminative Ability of the NIOX VERO NASAL to Differentiate Subjects With Primary Ciliary Dyskinesia From Healthy Controls

NCT02622061 is registered in ClinicalTrials.gov with Aerocrine AB as lead sponsor.

NCT NCT02622061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02622061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Investigation Determining the Discriminative Ability of the NIOX VERO NASAL to Differentiate Subjects With Primary Ciliary Dyskinesia From Healthy Controls
Lead sponsor
Aerocrine AB
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
April 28, 2017
Enrollment
163 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pcd